oxiracetam has been researched along with Neuroblastoma in 1 studies
oxiracetam: structure in first source
Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The in vitro study used a cell injury controller to damage SH-SY5Y cells and evaluate the effect of oxiracetam at a dosage of 100 nM." | 1.91 | Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury. ( Cho, SM; Choi, H; Han, SW; Hong, EP; Jeon, JP; Jung, H; Kim, JT; Kim, N; Lee, A; Lee, Y; Park, CH; Youn, DH, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Youn, DH | 1 |
| Han, SW | 1 |
| Kim, JT | 1 |
| Choi, H | 1 |
| Lee, A | 1 |
| Kim, N | 1 |
| Jung, H | 1 |
| Hong, EP | 1 |
| Park, CH | 1 |
| Lee, Y | 1 |
| Cho, SM | 1 |
| Jeon, JP | 1 |
1 other study available for oxiracetam and Neuroblastoma
| Article | Year |
|---|---|
Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury.
Topics: Animals; Anti-Inflammatory Agents; Brain Injuries, Traumatic; Caspases; Cognitive Dysfunction; Cyclo | 2023 |